Mesa Laboratories Inc S-3ASR, filed Apr 5, 2022

Mesa Laboratories Inc (MLAB)

S-3ASR 2022-04-05

Added on October 17, 2026

	Colorado			84-0872291
	(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification Number)

	Large accelerated filer ☒			Accelerated filer ☐			Non-accelerated filer ☐			Smaller reporting company ☐
										Emerging growth company ☐

	ABOUT THIS PROSPECTUS					1
	WHERE YOU CAN FIND ADDITIONAL INFORMATION					2
	INCORPORATION OF CERTAIN INFORMATION BY REFERENCE					2
	SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS					3
	RISK FACTORS					4
	ABOUT THE COMPANY					5
	DESCRIPTION OF CAPITAL STOCK					6
	DESCRIPTION OF DEBT SECURITIES					8
	DESCRIPTION OF DEPOSITARY SHARES					16
	DESCRIPTION OF WARRANTS					17
	DESCRIPTION OF PURCHASE CONTRACTS					18
	DESCRIPTION OF UNITS					19
	USE OF PROCEEDS					20
	PLAN OF DISTRIBUTION					21
	LEGAL MATTERS					25
	EXPERTS					25

	Amount to be Paid
SEC registration fee		$	(1)
Nasdaq listing fee			(2)
Accounting fees and expenses			(2)
Legal fees and expenses			(2)
Trustee and Transfer Agent fees and expenses			(2)
Printing fees			(2)
Miscellaneous			(2)
Total		$	(2)

	Exhibit No.			Description
	*1.1			Form of Underwriting Agreement.
	4.1			Form of Indenture.
	*4.2			Form of Certificate of Designations for Preferred Stock.
	*4.3			Form of Depositary Receipt.
	*4.4			Form of Depositary Agreement.
	*4.5			Form of Warrant.
	*4.6			Form of Warrant Agreement.
	*4.7			Form of Purchase Contract.
	*4.8			Form of Unit Certificate.
	*4.9			Form of Unit Agreement.

	Exhibit No.			Description
	5.1			Opinion of Davis Graham & Stubbs LLP.
	23.1			Consent of Plante & Moran, PLLC.
	23.2			Consent of Moss Adams LLP.
	23.3			Consent of Davis Graham & Stubbs LLP (included in Exhibit 5.1).
	24.1			Power of Attorney (included on signature page to this Registration Statement)
	25.1			Form T-1 Statement of Eligibility of Trustee for the Indenture.
	107			Filing Fees

				MESA LABORATORIES, INC. (Registrant)
				By:			/s/ GARY M. OWENS
							Gary M. Owens Chief Executive Officer

Name	Title	Date
/s/ JOHN J. SULLIVAN, PH.D. John J. Sullivan	Chairman of the Board of Directors	April 5, 2022
/s/ GARY M. OWENS Gary M. Owens	Chief Executive Officer, President, and Director	April 5, 2022
/s/ JOHN V. SAKYS John V. Sakys	Chief Financial and Chief Accounting Officer, and Treasurer	April 5, 2022
/s/ SHIRAZ LADIWALA Shiraz Ladiwala	Director	April 5, 2022
/s/ JOHN B. SCHMIEDER John B Schmieder	Director	April 5, 2022
/s/ JENNIFER S. ALLTOFT Jennifer S. Alltoft	Director	April 5, 2022

	Page

ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE	1

Section 1.1	Definitions	1
Section 1.2	Other Definitions	4
Section 1.3	Incorporation by Reference of Trust Indenture Act	4
Section 1.4	Rules of Construction	5

Section 2.1	Issuable in Series	5
Section 2.2	Establishment of Terms of Series of Securities	6
Section 2.3	Execution and Authentication	7
Section 2.4	Registrar and Paying Agent	8
Section 2.5	Paying Agent to Hold Money in Trust	9
Section 2.6	Securityholder Lists	9
Section 2.7	Transfer and Exchange	9
Section 2.8	Mutilated, Destroyed, Lost and Stolen Securities	10
Section 2.9	Outstanding Securities	10
Section 2.10	Treasury Securities	11
Section 2.11	Temporary Securities	11
Section 2.12	Cancellation	11
Section 2.13	Defaulted Interest	11
Section 2.14	Global Securities	12
Section 2.15	CUSIP Numbers	13

Section 3.1	Notice to Trustee	13
Section 3.2	Selection of Securities to be Redeemed	13
Section 3.3	Notice of Redemption	14
Section 3.4	Effect of Notice of Redemption	14
Section 3.5	Deposit of Redemption Price	15
Section 3.6	Securities Redeemed in Part	15

Section 4.1	Payment of Principal and Interest	15
Section 4.2	SEC Reports	15
Section 4.3	Compliance Certificate	15
Section 4.4	Stay, Extension and Usury Laws	16

Section 5.1	When Company May Merge, Etc	16
Section 5.2	Successor Corporation Substituted	16

Section 6.1	Events of Default	17
Section 6.2	Acceleration of Maturity; Rescission and Annulment	18
Section 6.3	Collection of Indebtedness and Suits for Enforcement by Trustee	19
Section 6.4	Trustee May File Proofs of Claim	19
Section 6.5	Trustee May Enforce Claims Without Possession of Securities	20
Section 6.6	Application of Money Collected	20
Section 6.7	Limitation on Suits	21
Section 6.8	Unconditional Right of Holders to Receive Principal and Interest	21
Section 6.9	Restoration of Rights and Remedies	21
Section 6.10	Rights and Remedies Cumulative	22
Section 6.11	Delay or Omission Not Waiver	22
Section 6.12	Control by Holders	22
Section 6.13	Waiver of Past Defaults	22
Section 6.14	Undertaking for Costs	23

Section 8.1	Satisfaction and Discharge of Indenture	28
Section 8.2	Application of Trust Funds; Indemnification	29
Section 8.3	Legal Defeasance of Securities of any Series	30
Section 8.4	Covenant Defeasance	31
Section 8.5	Repayment to Company	32
Section 8.6	Reinstatement	33

Section 10.1	Trust Indenture Act Controls	36
Section 10.2	Notices	36
Section 10.3	Communication by Holders with Other Holders	37
Section 10.4	Certificate and Opinion as to Conditions Precedent	37
Section 10.5	Statements Required in Certificate or Opinion	37
Section 10.6	Rules by Trustee and Agents	38
Section 10.7	Legal Holidays	38
Section 10.8	No Recourse Against Others	38
Section 10.9	Counterparts	38
Section 10.10	Governing Law	38
Section 10.11	No Adverse Interpretation of Other Agreements	38
Section 10.12	Successors	38
Section 10.13	Severability	39
Section 10.14	Table of Contents, Headings, Etc	39
Section 10.15	Securities in a Foreign Currency	39
Section 10.16	Judgment Currency	39

Section 11.1	Applicability of Article	40
Section 11.2	Satisfaction of Sinking Fund Payments with Securities	40
Section 11.3	Redemption of Securities for Sinking Fund	41

Section 7.1	Duties of Trustee	23
Section 7.2	Rights of Trustee	24
Section 7.3	Individual Rights of Trustee	25
Section 7.4	Trustee’s Disclaimer	25
Section 7.5	Notice of Defaults	26
Section 7.6	Reports by Trustee to Holders	26
Section 7.7	Compensation and Indemnity	26
Section 7.8	Replacement of Trustee	27
Section 7.9	Successor Trustee by Merger, Etc	28
Section 7.10	Eligibility; Disqualification	28
Section 7.11	Preferential Collection of Claims Against Company	28

Section 9.1	Without Consent of Holders	33
Section 9.2	With Consent of Holders	34
Section 9.3	Limitations	34
Section 9.4	Compliance with Trust Indenture Act	35
Section 9.5	Revocation and Effect of Consents	35
Section 9.6	Notation on or Exchange of Securities	35
Section 9.7	Trustee Protected	35

TERM		DEFINED IN SECTION
“Bankruptcy Law”		6.1
“Custodian”		6.1
“Event of Default”		6.1
“Judgment Currency”		10.16
“Legal Holiday”		10.7
“mandatory sinking fund payment”		11.1
“New York Banking Day”		10.16
“Notice Agent”		2.4
“optional sinking fund payment”		11.1
“Paying Agent”		2.4
“Registrar”		2.4
“Required Currency”		10.16
“successor person”		5.1

	Mesa Laboratories, Inc.

	By:
	Name:
	Its:

	U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee

	By:
	Name:
	Its:

Re:	Mesa Laboratories, Inc.
	Registration Statement on Form S-3

Colorado	84-0872291
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

	12/31/2021
Assets
Cash and Balances Due From Depository Institutions	$	21,114
Securities		0
Federal Funds		0
Loans & Lease Financing Receivables		0
Fixed Assets		0
Intangible Assets		0
Other Assets		402
Total Assets	$	21,516

Liabilities
Deposits	$	0
Fed Funds		0
Treasury Demand Notes		0
Trading Liabilities		0
Other Borrowed Money		0
Acceptances		0
Subordinated Notes and Debentures		0
Other Liabilities		43
Total Liabilities	$	43

Equity
Common and Preferred Stock		200
Surplus		800
Undivided Profits		20,473
Minority Interest in Subsidiaries		0
Total Equity Capital	$	21,473

Total Liabilities and Equity Capital	$	21,516